台基股份(300046.SZ):2022年度淨利預降45.56%-58.04%
格隆匯1月20日丨台基股份(300046.SZ)公佈2022年度業績預吿,報吿期歸屬於上市公司股東的淨利潤盈利1850萬元-2400萬元,比上年同期下降45.56%-58.04%;扣除非經常損益後的淨利潤盈利1990萬元-2540萬元,比上年同期下降30.27%—45.37%。
業績變動原因:1、受市場環境及疫情反覆的影響,公司主要原材料價格均有上漲,導致毛利率同比下降。2、公司實施股權激勵,計提了等待期的股份支付費用。3、根據相關企業會計準則的要求,對相關資產組計提減值損失。4、公司預計2022年度非經常性損益對淨利潤的影響金額約為140萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.